Podium to Practice: ESMO® 2025 – Melanoma: CHOPIN

Podium to Practice: ESMO® 2025 – Melanoma: CHOPIN

Podium to Practice: ESMO® 2025
Explore more from your favourite experts – click their name to access their entire library of content.
Icon Chair Speaker

Chair

Dr. Teresa Petrella

Icon Chair Speaker

Speakers

Dr. Marcus Butler

Prof. Caroline Robert

Studies / Trials Discussed

LBA59 – Combined Percutaneous Hepatic Perfusion with Ipilimumab plus Nivolumab in Metastatic Uveal Melanoma: a single center, open-label, randomized, phase 2 study (CHOPIN)

Studies/trials discussed:

LBA59 – Combined Percutaneous Hepatic Perfusion with Ipilimumab plus Nivolumab in Metastatic Uveal Melanoma: a single center, open-label, randomized, phase 2 study (CHOPIN)
Tagged